心脏衰竭中缺血性心脏病的蛋白质组概况:一个社区研究
Kayode O Kuku1, Maryam Hashemian1, Jungnam Joo2
1Heart Disease Phenomics Laboratory, Epidemiology and Community Health Branch, Division of Intramural Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
Mayo Clinic proceedings
|April 1, 2025
概括
缺血性心脏病 (IHD) 在心力衰竭 (HF) 中具有鲜明的蛋白质组特征. IHD显著增加了心血管死亡率在HF患者减少喷射分数 (EF).
科学领域:
- 心血管医学 心血管医学
- 蛋白质组学是指蛋白质组学.
- 心脏衰竭研究研究
背景情况:
- 缺血性心脏病 (IHD) 是患有心力衰竭 (HF) 的患者中普遍存在的并发症.
- 了解HF中IHD的分子基础和预后影响对于患者管理至关重要.
- 以前的研究还没有完全阐明心力衰竭队列中与IHD相关的蛋白质组特征.
研究的目的:
- 为了研究心力衰竭队列中普遍存在的IHD的临床特征.
- 分析结局,特别是心血管死亡率,与心力衰竭中的IHD相关.
- 在心力衰竭患者中识别和描述与IHD相关的血蛋白质组概况.
主要方法:
- 一个基于社区的心力衰竭队列 (N=1351) 与链接的医疗记录进行了研究.
- 血蛋白标 (7289) 用基于aptamer的测定方法进行测量.
- 使用因果特异性危险模型和线性回归来评估IHD,心血管死亡率,射出分数和蛋白质组形状之间的关联.
主要成果:
- 在678名患者中发现了缺血性心脏病 (平均年龄为78岁,40%为女性).
- IHD和心血管死亡率之间的关联因射出分数 (P相互作用=.002) 而显著改变.
- 在减少喷射分数组 (HR 2.14) 中,心血管疾病与5年心血管死亡率的增加有关,但在保存喷射分数组 (HR 1.04) 中没有;52种蛋白质与心血管疾病有关.
结论:
- 独特的蛋白质基因特征在心力衰竭中表现出缺血性心脏病,突出显示了HF表型化分子数据的价值.
- 缺血性心脏病对心血管死亡率具有显著的预后影响,特别是在心力衰竭患者中,心力衰竭患者的排泄分数减少.
- 这些发现强调,在评估心力衰竭中心血管风险时,需要考虑IHD状态和射出分数.
相关概念视频
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
38
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
38
Pathophysiology of Heart Failure
1.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
71
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
71
Proteomics
7.1K
A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
7.1K


